Tolterodine ER for the prevention of urge urinary incontinence in men undergoing HoLEP for BPH

Trial Profile

Tolterodine ER for the prevention of urge urinary incontinence in men undergoing HoLEP for BPH

Completed
Phase of Trial: Phase II

Latest Information Update: 28 Dec 2012

At a glance

  • Drugs Tolterodine (Primary)
  • Indications Benign prostatic hyperplasia; Overactive bladder; Urge incontinence
  • Focus Therapeutic Use
  • Most Recent Events

    • 28 Dec 2012 New trial record
    • 19 Oct 2012 Primary endpoint 'Frequency-of-urgency-episodes' has been met.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top